ArticleActa pharmaceutica Sinica. B2024

Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus.

Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.